Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS)
26.71 -1.06 (-3.82%) 04/10/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 26.71 unch (unch) 16:20 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
25.74
Day High
27.26
Open 27.14
Previous Close 27.77 27.77
Volume 2,145,100 2,145,100
Avg Vol 1,836,935 1,836,935
Stochastic %K 24.98% 24.98%
Weighted Alpha -42.44 -42.44
5-Day Change -1.81 (-6.35%) -1.81 (-6.35%)
52-Week Range 23.95 - 52.34 23.95 - 52.34
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,414,458
  • Shares Outstanding, K 158,965
  • Annual Sales, $ 705,140 K
  • Annual Income, $ -453,900 K
  • EBIT $ -475 M
  • EBITDA $ -484 M
  • 60-Month Beta 0.29
  • Price/Sales 5.75
  • Price/Cash Flow N/A
  • Price/Book 6.85

Options Overview Details

View History
  • Implied Volatility 77.53% ( -9.24%)
  • Historical Volatility 61.68%
  • IV Percentile 99%
  • IV Rank 85.13%
  • IV High 86.76% on 04/09/25
  • IV Low 24.62% on 10/17/24
  • Put/Call Vol Ratio 0.05
  • Today's Volume 157
  • Volume Avg (30-Day) 224
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 16,632
  • Open Int (30-Day) 16,129

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.12
  • Number of Estimates 8
  • High Estimate -1.00
  • Low Estimate -1.25
  • Prior Year -0.98
  • Growth Rate Est. (year over year) -14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.95 +11.52%
on 04/09/25
Period Open: 32.22
34.74 -23.11%
on 03/17/25
-5.51 (-17.10%)
since 03/10/25
3-Month
23.95 +11.52%
on 04/09/25
Period Open: 33.46
35.37 -24.48%
on 01/14/25
-6.75 (-20.17%)
since 01/10/25
52-Week
23.95 +11.52%
on 04/09/25
Period Open: 42.94
52.34 -48.97%
on 07/26/24
-16.23 (-37.80%)
since 04/10/24

Most Recent Stories

More News
Ionis Pharma Beats Expectations for Q4

The biotech outperformed expectations with better-than-expected revenue and a smaller-than-expected loss.

IONS : 26.71 (-3.82%)
Ionis Pharmaceuticals: Q4 Earnings Snapshot

Ionis Pharmaceuticals: Q4 Earnings Snapshot

IONS : 26.71 (-3.82%)
Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy?

Corcept Therapeutics Incorporated CORT has been having a fabulous 2024, with its share price increasing 60.5% year to date as of Nov. 5, 2024.This company engages in the discovery and development of drugs...

CORT : 67.73 (-7.18%)
COLL : 24.67 (-6.45%)
IONS : 26.71 (-3.82%)
Ionis Pharmaceuticals: Q3 Earnings Snapshot

Ionis Pharmaceuticals: Q3 Earnings Snapshot

IONS : 26.71 (-3.82%)
New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA

IONS : 26.71 (-3.82%)
BIIB : 113.38 (-5.90%)
IONS' Rare Neurology Disorder Candidate Gets FDA's Fast Track Tag

Ionis Pharmaceuticals, Inc. IONS announced that the FDA has granted a Fast Track designation to its investigational RNA-targeted therapy zilganersen for treating Alexander disease (AxD), an ultra-rare...

KRYS : 160.65 (-4.47%)
FULC : 2.63 (-8.85%)
IONS : 26.71 (-3.82%)
ANIP : 65.12 (-1.35%)
Ionis Pharmaceuticals: Q2 Earnings Snapshot

Ionis Pharmaceuticals: Q2 Earnings Snapshot

IONS : 26.71 (-3.82%)
Ionis Pharmaceuticals: Q1 Earnings Snapshot

Ionis Pharmaceuticals: Q1 Earnings Snapshot

IONS : 26.71 (-3.82%)
Ionis Pharmaceuticals: Q4 Earnings Snapshot

Ionis Pharmaceuticals: Q4 Earnings Snapshot

IONS : 26.71 (-3.82%)
Markets Today: Stock Index Futures Add to Record Highs on U.S. Economic Optimism

Morning Markets March E-Mini S&P 500 futures (ESH24 ) are up +0.35%, and March Nasdaq 100 E-Mini futures (NQH24 ) are up +0.57%, both at new all-time nearest-futures highs. Stock index futures this morning...

ESM25 : 5,273.75 (-0.53%)
NQM25 : 18,380.25 (-0.56%)
SMCI : 33.68 (-8.25%)
ZS : 195.36 (-3.34%)
M : 11.45 (-3.54%)
S : 17.51 (-7.01%)
IONS : 26.71 (-3.82%)
NS : 21.96 (-1.83%)
NET : 105.50 (-6.27%)
ADM : 44.48 (+0.23%)
BA : 155.52 (-3.30%)
RILY : 2.95 (-6.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.

See More

Key Turning Points

3rd Resistance Point 28.92
2nd Resistance Point 28.09
1st Resistance Point 27.40
Last Price 26.71
1st Support Level 25.88
2nd Support Level 25.05
3rd Support Level 24.36

See More

52-Week High 52.34
Fibonacci 61.8% 41.50
Fibonacci 50% 38.15
Fibonacci 38.2% 34.79
Last Price 26.71
52-Week Low 23.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar